158 related articles for article (PubMed ID: 30453269)
21. Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2.
Ren Z; Aerts JL; Vandenplas H; Wang JA; Gorbenko O; Chen JP; Giron P; Heirman C; Goyvaerts C; Zacksenhaus E; Minden MD; Stambolic V; Breckpot K; De Grève J
Cell Death Dis; 2016 Dec; 7(12):e2560. PubMed ID: 28005077
[TBL] [Abstract][Full Text] [Related]
22. DDX31 regulates the p53-HDM2 pathway and rRNA gene transcription through its interaction with NPM1 in renal cell carcinomas.
Fukawa T; Ono M; Matsuo T; Uehara H; Miki T; Nakamura Y; Kanayama HO; Katagiri T
Cancer Res; 2012 Nov; 72(22):5867-77. PubMed ID: 23019224
[TBL] [Abstract][Full Text] [Related]
23. Analysis of
Zajac M; Dolnik A; Stasiak G; Zaleska J; Kielbus M; Czapinski J; Schunn M; Correa SC; Glodkowska-Mrowka E; Sundaram RC; Jankowska-Lecka O; Schlenk RF; Döhner H; Döhner K; Stepulak A; Bullinger L; Giannopoulos K
Oncotarget; 2017 Nov; 8(56):95163-95175. PubMed ID: 29221119
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.
Poletto M; Malfatti MC; Dorjsuren D; Scognamiglio PL; Marasco D; Vascotto C; Jadhav A; Maloney DJ; Wilson DM; Simeonov A; Tell G
Mol Carcinog; 2016 May; 55(5):688-704. PubMed ID: 25865359
[TBL] [Abstract][Full Text] [Related]
25. Phosphoprotein DIGE profiles reflect blast differentiation, cytogenetic risk stratification, FLT3/NPM1 mutations and therapy response in acute myeloid leukaemia.
Forthun RB; Aasebø E; Rasinger JD; Bedringaas SL; Berven F; Selheim F; Bruserud Ø; Gjertsen BT
J Proteomics; 2018 Feb; 173():32-41. PubMed ID: 29175091
[TBL] [Abstract][Full Text] [Related]
26. N6L pseudopeptide interferes with nucleophosmin protein-protein interactions and sensitizes leukemic cells to chemotherapy.
De Cola A; Franceschini M; Di Matteo A; Colotti G; Celani R; Clemente E; Ippoliti R; Cimini AM; Dhez AC; Vallée B; Raineri F; Cascone I; Destouches D; De Laurenzi V; Courty J; Federici L
Cancer Lett; 2018 Jan; 412():272-282. PubMed ID: 29111347
[TBL] [Abstract][Full Text] [Related]
27. Interaction of CacyBP/SIP with NPM1 and its influence on NPM1 localization and function in oxidative stress.
Rosińska S; Filipek A
J Cell Physiol; 2018 Nov; 233(11):8826-8838. PubMed ID: 29806702
[TBL] [Abstract][Full Text] [Related]
28. The function of DNA binding protein nucleophosmin in AAV replication.
Satkunanathan S; Thorpe R; Zhao Y
Virology; 2017 Oct; 510():46-54. PubMed ID: 28704696
[TBL] [Abstract][Full Text] [Related]
29. Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation.
Yang F; Stenoien DL; Strittmatter EF; Wang J; Ding L; Lipton MS; Monroe ME; Nicora CD; Gristenko MA; Tang K; Fang R; Adkins JN; Camp DG; Chen DJ; Smith RD
J Proteome Res; 2006 May; 5(5):1252-60. PubMed ID: 16674116
[TBL] [Abstract][Full Text] [Related]
30. Role of nucleophosmin in embryonic development and tumorigenesis.
Grisendi S; Bernardi R; Rossi M; Cheng K; Khandker L; Manova K; Pandolfi PP
Nature; 2005 Sep; 437(7055):147-53. PubMed ID: 16007073
[TBL] [Abstract][Full Text] [Related]
31. Nucleolin and nucleophosmin: nucleolar proteins with multiple functions in DNA repair.
Scott DD; Oeffinger M
Biochem Cell Biol; 2016 Oct; 94(5):419-432. PubMed ID: 27673355
[TBL] [Abstract][Full Text] [Related]
32. Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling.
Xian J; Shao H; Chen X; Zhang S; Quan J; Zou Q; Jin H; Zhang L
Int J Biol Sci; 2016; 12(2):144-55. PubMed ID: 26884713
[TBL] [Abstract][Full Text] [Related]
33. Glycolytic Enzyme PKM2 Mediates Autophagic Activation to Promote Cell Survival in NPM1-Mutated Leukemia.
Wang L; Yang L; Yang Z; Tang Y; Tao Y; Zhan Q; Lei L; Jing Y; Jiang X; Jin H; Zou Q; Xian J; Zhang L
Int J Biol Sci; 2019; 15(4):882-894. PubMed ID: 30906218
[TBL] [Abstract][Full Text] [Related]
34. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
[TBL] [Abstract][Full Text] [Related]
35. NPM1 activates metabolic changes by inhibiting FBP1 while promoting the tumorigenicity of pancreatic cancer cells.
Zhu Y; Shi M; Chen H; Gu J; Zhang J; Shen B; Deng X; Xie J; Zhan X; Peng C
Oncotarget; 2015 Aug; 6(25):21443-51. PubMed ID: 26068981
[TBL] [Abstract][Full Text] [Related]
36. Nucleophosmin: from structure and function to disease development.
Box JK; Paquet N; Adams MN; Boucher D; Bolderson E; O'Byrne KJ; Richard DJ
BMC Mol Biol; 2016 Aug; 17(1):19. PubMed ID: 27553022
[TBL] [Abstract][Full Text] [Related]
37. [Research on NPM1 gene mutations in acute myeloid leukemia].
Chen HY; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):258-62. PubMed ID: 23484732
[TBL] [Abstract][Full Text] [Related]
38. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
39. TGF-β-activated kinase 1 promotes cell cycle arrest and cell survival of X-ray irradiated HeLa cells dependent on p21 induction but independent of NF-κB, p38 MAPK and ERK phosphorylations.
Furusawa Y; Wei ZL; Sakurai H; Tabuchi Y; Li P; Zhao QL; Nomura T; Saiki I; Kondo T
Radiat Res; 2012 Jun; 177(6):766-74. PubMed ID: 22490020
[TBL] [Abstract][Full Text] [Related]
40. NPM1 Mutant Mediated PML Delocalization and Stabilization Enhances Autophagy and Cell Survival in Leukemic Cells.
Zou Q; Tan S; Yang Z; Zhan Q; Jin H; Xian J; Zhang S; Yang L; Wang L; Zhang L
Theranostics; 2017; 7(8):2289-2304. PubMed ID: 28740552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]